Taken together, these results provide a glimpse into the critical role of NME4 in the biosynthesis of TG and lipogenesis, and the progression of NAFLD, shedding light on the development of novel therapeutic strategies for NAFLD and related diseases. Here, NME4 is linked to metabolic dysfunction-associated steatotic liver disease.